Besides, inhibition of PI3K-AKT-mTOR pathway in pancreatic cancer cells can inhibit cancer-associated fibroblasts (CAF), reduce interstitial fibrosis, and alter pancreatic cancer tumor microenvironment (TME), which will thereby increase the lethality of chemotherapy drugs 137. Here, MTOR is linked to pancreatic neoplasm.